Solid tumor therapeutics (HLB Life Science)

N/A

Report date: 2025/01/26 17:13:14
NME

Base Information

Drug NameSolid tumor therapeutics (HLB Life Science)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApoptosis stimulantsCell cycle inhibitors
TargetsUpdating
Therapy Area/IndicationsSolid tumoursLung NeoplasmsPancreatic Neoplasms +[6
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLSK NRDO Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHlb Life Science Co Ltd
Inactive CompaniesLSK NRDO Co Ltd
Active IndicationsSolid tumoursLung NeoplasmsPancreatic Neoplasms +[6
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A